Literature DB >> 35673448

Metabolic syndrome and underlying genetic determinants-A systematic review.

Sanjeev Rana1, Shafat Ali2, Hilal Ahmad Wani3, Qazi Danish Mushtaq4, Swarkar Sharma5, Muneeb U Rehman6.   

Abstract

The metabolic syndrome is a cluster of heritable and related traits which has been associated with a range of pathophysiological factors including dyslipidaemia, abdominal obesity, increased fasting plasma glucose (FPG) and hypertension. The documented genetic basis of the metabolic syndrome include several chromosomal positions, numerous candidate gene-associated polymorphisms, different genetic variants, which are linked to the syndrome either as a trait or entities mainly linked to metabolic process. Additionally, the latest findings related to the contribution of epigenetic mechanisms, microRNAs, sporadic variants, non-coding RNAs, and assessing the role of genes in molecular systems has enhanced our understanding of the syndrome. Considerable work has been done to understand the underlying disease mechanisms by elucidating its genetic etiology. Nonetheless, a common shared genetic cause has not been established to clarify the coexistence of their components and further investigation is required. While mostly neglected and rarely known, hereditary predisposition needs to be studied, including with the current defective phenotypic condition descriptions. Metabolic syndrome is a multi-faceted characteristic with abundant properties and the condition can arise from interactions between environmental variables such as physical inactivity, caloric obesity and genetic susceptibility. Although there is support for genetic determinants from family and twin research, there is still no recognised genomic DNA marker for genetic association and linkages with quite a long way off potential for clinical application. In the present review efforts have been made to through light on the various genetic determinants with large effects that underlie with the association of these traits to this syndrome. The heterogeneity and multifactorial heritability of MetS, however, has been a challenge towards understanding the factors underlying the association of these traits. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  Determinants; Family; Gene polymorphism; Linkage; Metabolic syndrome; Phenotype; Predisposition; Twin

Year:  2022        PMID: 35673448      PMCID: PMC9167205          DOI: 10.1007/s40200-022-01009-z

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  128 in total

1.  The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients.

Authors:  Luciana A Costa; Luis H Canani; Ana L Maia; Jorge L Gross
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

2.  The metabolic syndrome.

Authors:  Robert H Eckel; K G M M Alberti; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2010-01-16       Impact factor: 79.321

Review 3.  Uncloaking the genetic determinants of metabolic syndrome.

Authors:  Piya Lahiry; Rebecca L Pollex; Robert A Hegele
Journal:  J Nutrigenet Nutrigenomics       Date:  2008-02-20

4.  Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

Authors:  Thang S Han; Naveed Sattar; Ken Williams; Clicerio Gonzalez-Villalpando; Michael E J Lean; Steven M Haffner
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

Review 5.  Genetics of metabolic syndrome.

Authors:  Alena Stančáková; Markku Laakso
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

6.  The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study.

Authors:  W Chen; S R Srinivasan; A Elkasabany; G S Berenson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

7.  Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women.

Authors:  Debbie A Lawlor; George Davey Smith; Shah Ebrahim; Claire Thompson; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2005-08-02       Impact factor: 5.958

8.  C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.

Authors:  Martin K Rutter; James B Meigs; Lisa M Sullivan; Ralph B D'Agostino; Peter W F Wilson
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

9.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

Review 10.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

View more
  2 in total

Review 1.  The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review.

Authors:  Siting Gao; Qin Feng
Journal:  Drug Des Devel Ther       Date:  2022-09-30       Impact factor: 4.319

2.  Susceptibility Loci for Type 2 Diabetes in the Ethnically Endogamous Indian Sindhi Population: A Pooled Blood Genome-Wide Association Study.

Authors:  Kanchan V Pipal; Manju Mamtani; Ashwini A Patel; Sujeet G Jaiswal; Manisha T Jaisinghani; Hemant Kulkarni
Journal:  Genes (Basel)       Date:  2022-07-22       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.